TScan Therapeutics, Inc. (TCRX)
NASDAQ
$0.92+1.05%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 299,139
- 52-week high
- —
- 52-week low
- —
- Open
- $0.94
- Day high
- $0.97
- Day low
- $0.89
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $10.33M | -$129.77M | -$1.00 |
| 2024 | $2.82M | -$127.5M | -$1.14 |
| 2023 | $21.05M | -$89.22M | -$1.36 |
| 2022 | $13.54M | -$66.22M | -$2.75 |
| 2021 | $10.14M | -$48.63M | -$4.17 |
About TScan Therapeutics, Inc.
A company overview for TScan Therapeutics, Inc. is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is TScan Therapeutics, Inc.'s stock price today?
- TCRX is trading at $0.92 as of Jul 20, 2026.
- Does TScan Therapeutics, Inc. pay a dividend?
- TScan Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.